STOCK TITAN

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced participation in two upcoming investor conferences in March 2022. The Cowen 42nd Annual Health Care Conference will feature a fireside chat on March 9, 2022, at 12:50 p.m. ET, while the Oppenheimer 32nd Annual Healthcare Conference will take place on March 16, 2022, at 12:40 p.m. ET. Both events will be accessible via live webcast on the company’s website, with replays available for 90 days post-event. Apellis focuses on innovative therapies for diseases linked to the complement system.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences in March:

  • Cowen 42nd Annual Health Care Conference: Fireside chat on Wednesday, March 9, 2022 at 12:50 p.m. ET.
  • Oppenheimer 32nd Annual Healthcare Conference: Fireside chat on Wednesday, March 16, 2022 at 12:40 p.m. ET.

The conference events will be available via live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. Replays of the webcasts will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178

 


FAQ

What conferences will Apellis Pharmaceuticals participate in March 2022?

Apellis Pharmaceuticals will participate in the Cowen 42nd Annual Health Care Conference on March 9, 2022, and the Oppenheimer 32nd Annual Healthcare Conference on March 16, 2022.

When is the Cowen 42nd Annual Health Care Conference?

The Cowen 42nd Annual Health Care Conference will be held on March 9, 2022, at 12:50 p.m. ET.

What is the date and time for the Oppenheimer 32nd Annual Healthcare Conference?

The Oppenheimer 32nd Annual Healthcare Conference will take place on March 16, 2022, at 12:40 p.m. ET.

How can I access the webcasts for Apellis Pharmaceuticals' investor conferences?

The webcasts for Apellis Pharmaceuticals' investor conferences can be accessed from the 'Events and Presentations' page on the company's website.

Will the webcasts for the investor conferences be available after the events?

Yes, replays of the webcasts will be available for 90 days following each event.

Apellis Pharmaceuticals, Inc.

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Stock Data

4.11B
105.50M
13.98%
99.97%
18.64%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WALTHAM